Related Experiment Video
Updated: Apr 12, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Kinetic index combining native and postcontrast myocardial T1 in hypertrophic cardiomyopathy
Nadjia Kachenoura1, Laila Besson-Hajji1,2,3,4, Martin J Graves5
1Sorbonne Universités, UPMC Univ Paris 06, INSERM 1146, CNRS 7371, Laboratoire d'Imagerie Biomédicale, F-75013, Paris, France.
Insights
Native T1* and T1* decay indices accurately characterize hypertrophic cardiomyopathy (HCM) and its structural changes. These MRI-based measures are more effective than extracellular volume (ECV) for diagnosing HCM.
Area of Science:
- Cardiovascular MRI
- Cardiac Imaging
- Hypertrophic Cardiomyopathy Research
Background:
- Hypertrophic cardiomyopathy (HCM) involves myocardial structural changes.
- Accurate characterization of these changes is crucial for diagnosis and management.
- Novel imaging biomarkers are needed to improve diagnostic capabilities.
Purpose of the Study:
- To evaluate the ability of pre- and postcontrast apparent T1* indices to characterize myocardial structural changes in HCM.
- To assess the combined utility of T1* indices for HCM characterization.
- To compare the diagnostic performance of T1* indices with extracellular volume (ECV).
Main Methods:
- T1 mapping using MOLLI sequence on a 1.5T magnet.
- Inclusion of 17 HCM patients and 18 controls.
- Measurement of native T1 (T1*Native), extracellular volume (ECV), and T1* decay postcontrast.
- Correlation analysis with left ventricular (LV) indices (wall thickness, mass index).
- Receiver operator curve (ROC) analysis for diagnostic accuracy.
Main Results:
- Significant differences in T1*Native, ECV20min, and T1*decay between controls and HCM patients (P < 0.001).
- T1*Native and T1*decay showed higher correlation with LV structure (wall thickness, mass index) than ECV.
- T1*Native (97.1%) and T1*decay (91.2%) demonstrated higher accuracy in characterizing HCM compared to ECV (69%).
Conclusions:
- Native T1* and T1* decay indices effectively characterize HCM.
- These T1* indices offer superior diagnostic accuracy for HCM compared to ECV.
- T1* indices are valuable for HCM characterization, even without hypertrophy or late-gadolinium enhancement.
Background:
To evaluate ability of pre- and postcontrast apparent T1* indices, as well as their combination to characterize myocardial structural changes in hypertrophic cardiomyopathy (HCM).
Methods:
Study protocol was approved by institutional review board and informed consent was obtained. T1 mapping was performed using MOLLI sequence (1.5T magnet) on: (i) tubes with known T1 and varied heart-rates (HR), (ii) 17 HCM (55 ± 15 years) and 18 controls (49 ± 16 years), before contrast and every 5 min over 20 min postcontrast. Global and segmental native T1 (T1*Native ), extracellular volume (ECV) and percentage of decrease in myocardial T1* (T1*decay = 100·[1-T1*Post-contrast /T1*Native ]) were estimated. Correlation coefficients of associations between T1 and LV indices, such as left ventricular wall thickness (WT) and mass index (LVMi) were provided. Receiver operator curve analysis was performed on per-patient basis to assess ability of T1* indices to identify HCM.
Results:
While up to a T1* of 1000 ms the effect of HR was minor, it was more pronounced above 1000 ms. T1*Native (754 ± 76 ms versus 1014 ± 130 ms, P < 0.001), ECV20min (23 ± 5% versus 27 ± 4%, P = 0.005), and T1*decay5, 10, 15 or 20min (38 ± 8% versus 54 ± 6%, P < 0.001) showed significant differences between controls and HCM. Correlation coefficients for associations with WT and LVMi were higher for T1*Native and T1decay, independent of acquisition time (with WT/LVMi: r = 0.58/0.44 (P < 0.05) for T1*Native ; r = 0.23 (P < 0.05)/0.23 for ECV20min ; r > 0.51/ > 0.45(P < 0.05) for T1*decay5, 20min ). T1*Native (97.1%) and T1*decay (91.2%) characterized HCM with higher accuracy (P < 0.02) than ECV (69%).
Conclusion:
T1*Native and T1*decay were able to characterize HCM more accurately than ECV, even in the absence of myocardial hypertrophy and late-gadolinium enhancement.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imaging Studies for Cardiovascular System IV: CMRI

